U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1989
66
Substance Class Protein
Created
by admin
on Sat Jun 26 18:11:49 UTC 2021
Edited
by admin
on Sat Jun 26 18:11:49 UTC 2021
Protein Sub Type
Sequence Type COMPLETE
Record UNII
E211KPY694
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
BOTULINUM TOXIN TYPE A
JAN   VANDF   WHO-DD  
Common Name English
BOTULINUM TOXIN TYPE A [WHO-DD]
Common Name English
BOTULINUM TOXIN TYPE A [VANDF]
Common Name English
ANT-1403
Code English
AGN-151607
Common Name English
BOTULINUM A TOXIN [MART.]
Common Name English
BOTULIN A [MI]
Common Name English
RT001 (BOTULINUM TOXIN A)
Code English
EC 3.4.24.69
Common Name English
BOTULIN A
MI  
Common Name English
ANT-1207
Code English
BOTULINUM TOXIN TYPE A [JAN]
Common Name English
BOTULINUM A TOXIN
MART.  
Common Name English
BOTULINUM TOXIN A
Common Name English
BTX-A
Common Name English
BOTULINUM NEUROTOXIN TYPE A (EC 3.4.24.69) FROM CLOSTRIDIUM BOTULINUM
Common Name English
ONACLOSTOX [HSDB]
Common Name English
RT-001 (BOTULINUM TOXIN A)
Code English
ANT-1401
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 483
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 35789
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
NDF-RT N0000175771
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 114198
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 64591
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 56591
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 9885
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 128299
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
NDF-RT N0000175770
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
NCI_THESAURUS C296
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
Code System Code Type Description
ECHA (EC/EINECS)
297-253-4
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
LACTMED
PrabotulinumtoxinA
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
MERCK INDEX
M2632
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY Merck Index
DRUG CENTRAL
5368
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
RXCUI
1712
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
FDA UNII
E211KPY694
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
CAS
93384-43-1
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
NCI_THESAURUS
C82623
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
EVMPD
SUB13117MIG
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
DRUG BANK
DB00083
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
LACTMED
Botulin A
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
From To
1_6 2_429
1_787 1_832
Related Record Type Details
NX-01
INHIBITOR -> TARGET
RELABOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
NX-11
INHIBITOR -> TARGET
ONABOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
ABOBOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
DAXIBOTULINUMTOXIN A
SUB_CONCEPT->SUBSTANCE
NX-02
INHIBITOR -> TARGET
EVABOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
INCOBOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
BOTULINUM TOXIN TYPE A
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966